Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group The Peptide Ban Is Ending: FDA Peptides Explained Apple Podcasts Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link